Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Myung Gull Lee

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Living Beings

Concepts & Ideas

Procedures

Anatomy

Liver
Kidney

Chemicals & Drugs

Phenomena

Disorders

Protein-Energy Malnutrition

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
44
Kim, Seok-Ho
31
Kim, Won Bae
29
Kim, Sang Geon
23
Han, KS
13
Kim, YG
13
Shim, Hyun
13
Shim, Chang-Koo
10
Kim, ND
9
Chung, Suk-Jae
9
Chang, MS
9
Lee, JW
9
Yoon, WH
9
Shin, Wan
8
Kim, Yoon Gyoon
8
Chiou, Win

Sign-in to see all Coauthors

Publications

TOP 3
Kim Young Woo; Lee Sung Min; Shin Sang Mi; Hwang Se Jin; Brooks Janie S; Kang Hee Eun; Lee Myung Gull; Kim Sang Chan; Kim Sang Geon
Efficacy of sauchinone as a novel AMPK-activating lignan for preventing iron-induced oxidative stress and liver injury.
Brooks Samuel Carroll; Brooks Janie Sue; Lee Woo Hyung; Lee Myung Gull; Kim Sang Geon
Therapeutic potential of dithiolethiones for hepatic diseases.
Lee T-H; Cho H K; Cho Y H; Lee M-G
Development of an effective method for dendritic cell immunotherapy of mouse melanoma.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Myung Gull Lee (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Kim Young Woo; Lee Sung Min; Shin Sang Mi; Hwang Se Jin; Brooks Janie S; Kang Hee Eun; Lee Myung Gull; Kim Sang Chan; Kim Sang Geon
Efficacy of sauchinone as a novel AMPK-activating lignan for preventing iron-induced oxidative stress and liver injury.
Free radical biology & medicine 2009;47(7):1082-92.
2009: Brooks Samuel Carroll; Brooks Janie Sue; Lee Woo Hyung; Lee Myung Gull; Kim Sang Geon
Therapeutic potential of dithiolethiones for hepatic diseases.
Pharmacology & therapeutics 2009;124(1):31-43.
2009: Lee T-H; Cho H K; Cho Y H; Lee M-G
Development of an effective method for dendritic cell immunotherapy of mouse melanoma.
Scandinavian journal of immunology 2009;70(2):85-92.
2009: Kang H E; Cho Y K; Jung H Y; Choi K Y; Sohn S I; Baek S R; Lee M G
Pharmacokinetics and first-pass effects of liquiritigenin in rats: low bioavailability is primarily due to extensive gastrointestinal first-pass effect.
Xenobiotica; the fate of foreign compounds in biological systems 2009;39(6):465-75.
2009: Kang H E; Bae S K; Yoo M; Lee D C; Kim Y G; Lee M G
Interaction between udenafil and tamsulosin in rats: non-competitive inhibition of tamsulosin metabolism by udenafil via hepatic CYP3A1/2.
British journal of pharmacology 2009;156(6):1009-18.
2009: Ahn C Y; Bae S K; Bae S H; Kim T; Jung Y S; Kim Y C; Lee M G; Shin W G
Pharmacokinetics of oltipraz in diabetic rats with liver cirrhosis.
British journal of pharmacology 2009;156(6):1019-28.
2009: Kim Young Woo; Kang Hee Eun; Lee Myung Gull; Hwang Se Jin; Kim Sang Chan; Lee Chang Ho; Kim Sang Geon
Liquiritigenin, a flavonoid aglycone from licorice, has a choleretic effect and the ability to induce hepatic transporters and phase-II enzymes.
American journal of physiology. Gastrointestinal and liver physiology 2009;296(2):G372-81.
2009: Kang Min Kyung; Bae Soo Kyung; Kim Jin Wan; Lee Myung Gull
Pharmacokinetic interaction between oltipraz and silymarin in rats.
Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Société canadienne des sciences pharmaceutiques 2009;12(1):1-16.
2008: Yang Kyung Hee; Lee Myung Gull
Effects of endotoxin derived from Escherichia coli lipopolysaccharide on the pharmacokinetics of drugs.
Archives of pharmacal research 2008;31(9):1073-86.
2008: Lee Joo Hyun; Oh Jung Mi; Lee Myung Gull
Effects of water deprivation on drug pharmacokinetics: correlation between drug metabolism and hepatic CYP isozymes.
Archives of pharmacal research 2008;31(8):951-64.
2008: Chung H J; Lee I; Lee M G
Effects of water deprivation for 72 h on the pharmacokinetics of ipriflavone in rats.
Research in veterinary science 2008;85(1):149-55.
2008: Choi Y H; Chung S J; Lee M G
Pharmacokinetic interaction between DA-8159, a new erectogenic, and metformin in rats: competitive inhibition of metabolism via hepatic CYP3A1/2.
British journal of pharmacology 2008;153(7):1568-78.
2007: Oh E Y; Bae S K; Kwon J W; You M; Lee D C; Lee M G
Pharmacokinetic and pharmacodynamic consequences of inhibition of terazosin metabolism via CYP3A1 and/or 3A2 by DA-8159, an erectogenic, in rats.
British journal of pharmacology 2007;151(1):24-34.
2007: Lee Joo Hyun; Lee Myung Gull
Dose-dependent pharmacokinetics of telithromycin after intravenous and oral administration to rats: contribution of intestinal first-pass effect to low bioavailability.
Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Société canadienne des sciences pharmaceutiques 2007;10(1):37-50.
2006: Kim Yu Chul; Lee Inchul; Kim Sang Geon; Ko Seong-Hee; Lee Myung Gull; Kim So Hee
Effects of glucose supplementation on the pharmacokinetics of intravenous chlorzoxazone in rats with water deprivation for 72 h.
Life sciences 2006;79(23):2179-86.
2006: Choi Y H; Lee M G
Effects of enzyme inducers and inhibitors on the pharmacokinetics of metformin in rats: involvement of CYP2C11, 2D1 and 3A1/2 for the metabolism of metformin.
British journal of pharmacology 2006;149(4):424-30.
2006: Lee Myung Gull; Lee Joo Hyun; Oh Jung Mi
Pharmacokinetic changes of drugs in rat model of acute renal failure induced by uranyl nitrate: correlation between drug metabolism and hepatic microsomal cytochrome P450 isozymes.
Current clinical pharmacology 2006;1(2):193-205.
2006: Bae Soo Kyung; Kim Ji Young; Yang Si Hyung; Kim Jin Wan; Kim Taekrho; Lee Myung Gull
Pharmacokinetics of oltipraz in rat models of diabetes mellitus induced by alloxan or streptozotocin.
Life sciences 2006;78(20):2287-94.
2006: Kim Ji Young; Kim Yu Chul; Lee Myung Gull; Kwon Jong Won; Yoo Moohi
Effects of water deprivation on the pharmacokinetics of DA-8159, a new erectogenic, in rats.
Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Société canadienne des sciences pharmaceutiques 2006;9(1):10-21.
2005: Cho Il Je; Lee Ae Kyung; Lee Song Jin; Lee Myung Gull; Kim Sang Geon
Repression by oxidative stress of iNOS and cytokine gene induction in macrophages results from AP-1 and NF-kappaB inhibition mediated by B cell translocation gene-1 activation.
Free radical biology & medicine 2005;39(11):1523-36.
2005: Lee Shin Jung; Bae Soo Kyung; Kwon Jong Won; You Moohi; Lee Duk Chul; Lee Myung Gull
Pharmacokinetic interaction between 5-[2-propyloxy-5-(1-methyl-2-pyrollidinylethylamidosulfonyl)phenyl]-1-methyl-3-propyl-1,6-dihydro-7H-pyrazolo (4,3-d) pyrimidine-7-one (DA-8159) and nitroglycerin in rats.
The Journal of pharmacy and pharmacology 2005;57(11):1397-405.
2005: Kim Yu Chul; Lee Ae Kyung; Lee Joo Hyun; Lee Inchul; Lee Duk Chul; Kim So Hee; Kim Sang Geon; Lee Myung Gull
Pharmacokinetics of theophylline in diabetes mellitus rats: induction of CYP1A2 and CYP2E1 on 1,3-dimethyluric acid formation.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 2005;26(1):114-23.
2005: Bae Soo Kyung; Lee Shin Jung; Kim Young Hoon; Kim Taekrho; Lee Myung Gull
Effect of enzyme inducers and inhibitors on the pharmacokinetics of oltipraz in rats.
The Journal of pharmacy and pharmacology 2005;57(4):443-52.
2004: Lee Joo Hyun; Suh Ok Kyung; Lee Myung Gull
Pharmacokinetic changes in drugs during protein-calorie malnutrition: correlation between drug metabolism and hepatic microsomal cytochrome P450 isozymes.
Archives of pharmacal research 2004;27(7):693-712.
2004: Bae S K; Kim E J; Lim C H; Lee J S; Kim Y G; Lee M G
Bioequivalence of pravastatin tablet formulations assessed in Korean males.
International journal of clinical pharmacology and therapeutics 2004;42(5):301-6.
2004: Bae Soo Kyung; Lee Shin Jung; Kwon Jong Won; Kim Won Bae; Lee Myung Gull
Effects of protein-calorie malnutrition on the pharmacokinetics of DA-7867, a new oxazolidinone, in rats.
The Journal of pharmacy and pharmacology 2004;56(5):635-42.
2004: Chung Hye Jin; Kim Yu Chul; Koo Chang Hui; Lee Myung Gull
Determination of 1-(3-fluoro-4-hydroxy-5-mercaptomethyltetrahydrofuran-2-yl)-5-methyl-1H-pyrimidine-2,4-dione in rat plasma and urine by high-performance liquid chromatography.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2004;803(2):367-70.
2003: Kim Y C; Kim E J; Lee E D; Kim J H; Jang S W; Kim Y G; Kwon J W; Kim W B; Lee M G
Comparative bioavailability of silibinin in healthy male volunteers.
International journal of clinical pharmacology and therapeutics 2003;41(12):593-6.
2003: Kim Yu Chul; Lee Myung Gull; Ko Seong-Hee; Kim So Hee
Effects of the rate and composition of fluid replacement on the pharmacokinetics and pharmacodynamics of intravenous torasemide.
The Journal of pharmacy and pharmacology 2003;55(11):1515-22.
2003: Bae Soo Kyung; Kim Eun Jung; Chung Suk Jae; Kim Sang Geon; Lee Myung Gull
Pharmacokinetic interaction between oltipraz and dimethyl-4,4'-dimethoxy-5,6,5',6'-dimethylene dioxybiphenyl-2,2'-dicarboxylate (DDB) after single intravenous and oral administration to rats.
The Journal of pharmacy and pharmacology 2003;55(9):1241-9.
2003: Bae Soo Kyung; Kim Eun Jung; Kwon Jong Won; Kim Won Bae; Lee Myung Gull
High-performance liquid chromatographic analysis of DA-7867, a new oxazolidinone, in human plasma and urine and in rat tissue homogenates.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2003;794(2):397-403.
2003: Yu Su Yeon; Bae Soo Kyung; Kim Eun Jung; Kim Yoon Gyoon; Kim Sun-Ok; Lee Dong Ha; Lim Hong; Lee Myung Gull
Dose-independent pharmacokinetics of a new reversible proton pump inhibitor, KR-60436, after intravenous and oral administration to rats: gastrointestinal first-pass effect.
Journal of pharmaceutical sciences 2003;92(8):1592-603.
2003: Lee Young-Mi; Song Im-Sook; Kim Sang Geon; Lee Myung Gull; Chung Suk-Jae; Shim Chang-Koo
The suppressed expression and functional activity of hepatic P-glycoprotein in rats with protein-calorie malnutrition.
Journal of pharmaceutical sciences 2003;92(7):1323-30.
2003: Chung Won- Suk; Kim Eun Jung; Lee Inchul; Kim Sang Geon; Lee Myung Gull; Kim So Hee
Effects of recombinant human growth hormone on the pharmacokinetics of intravenous chlorzoxazone in rats with acute renal failure induced by uranyl nitrate.
Life sciences 2003;73(3):253-63.
2003: Moon Young Jin; Lee Ae Kyung; Chung Hye Chin; Kim Eun Jung; Kim So Hee; Lee Duk Chul; Lee Inchul; Kim Sang Geon; Lee Myung Gull
Effects of acute renal failure on the pharmacokinetics of chlorzoxazone in rats.
Drug metabolism and disposition: the biological fate of chemicals 2003;31(6):776-84.
2003: Yim Yoon Gyoon; Cho Min Kyung; Kwon Jong Won; Kim Dong-Hyun; Kim Sang Geon; Lee Myung Gull
Effects of cysteine on the pharmacokinetics of intravenous 2-(allylthio)pyrazine, a new chemoprotective agent, in rats with protein-calorie malnutrition.
International journal of pharmaceutics 2003;255(1-2):1-11.
2003: Kim Eun Jung; Suh Ok Kyung; Lee Myung Gull
Pharmacokinetics of intravenous theophylline in mutant Nagase analbuminemic rats.
Life sciences 2003;72(11):1231-45.
2002: Yu Su Yeon; Chung Hye Chin; Kim Eun Jung; Kim So Hee; Lee Inchull; Kim Sang Geon; Lee Myung Gull
Effects of acute renal failure induced by uranyl nitrate on the pharmacokinetics of intravenous theophylline in rats: the role of CYP2E1 induction in 1,3-dimethyluric acid formation.
The Journal of pharmacy and pharmacology 2002;54(12):1687-92.
2002: Song Im-Sook; Lee In-Kyoung; Chung Suk-Jae; Kim Sang-Geon; Lee Myung-Gull; Shim Chang-Koo
Effect of nitric oxide on the sinusoidal uptake of organic cations and anions by isolated hepatocytes.
Archives of pharmacal research 2002;25(6):984-8.
2002: Lee In-Kyung; Lee Young-Mi; Song Im-Sook; Chung Suk-Jae; Kim Sang-Geon; Lee Myung-Gull; Shim Chang-Koo
Hepatobiliary excretion of tributylmethylamonium in rats with lipopolysaccharide-induced acute inflammation.
Archives of pharmacal research 2002;25(6):969-72.
2002: Kang Keon Wook; Kim Yoon Gyoon; Cho Min Kyong; Bae Soo Kyung; Kim Choon Won; Lee Myung Gull; Kim Sang Geon
Oltipraz regenerates cirrhotic liver through CCAAT/enhancer binding protein-mediated stellate cell inactivation.
The FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2002;16(14):1988-90.
2002: Han Hee; Kim Sang-Geon; Lee Myung-Gull; Shim Chang-Koo; Chung Suk-Jae
Mechanism of the reduced elimination clearance of benzylpenicillin from cerebrospinal fluid in rats with intracisternal administration of lipopolysaccharide.
Drug metabolism and disposition: the biological fate of chemicals 2002;30(11):1214-20.
2002: Shim Hyun Joo; Lee Eun Joo; Jung Young Hee; Kim So Hee; Kim Soon Hoe; Yoo Moohi; Kwon Jong Won; Kim Won Bae; Lee Myung Gull
Determination of a new phosphodiesterase V inhibitor, DA-8159, in plasma and urine by high-performance liquid chromatography.
Journal of pharmaceutical and biomedical analysis 2002;30(3):527-33.
2002: Kim So Hee; Moon Young Jin; Ryu Chung-Kyu; Lee Myung Gull
Determination of a new isoquinolinedione derivative, 7-anilino-5,8-isoquinolinedione, in plasma, urine and tissue homogenates by high-performance liquid chromatography.
Journal of pharmaceutical and biomedical analysis 2002;30(3):519-26.
2002: Kim Eun Jung; Lee Mi Hye; Kim So Hee; Kim Sun-Ok; Lee Dong Ha; Lim Hong Lim; Lee Hye Suk; Lee Myung Gull
Determination of a new reversible proton pump inhibitor, DBM-819, in human plasma and urine, and rat tissue homogenates by high-performance liquid chromatography.
Journal of pharmaceutical and biomedical analysis 2002;30(3):511-8.
2002: Kim So Hee; Kwon Jong Won; Kim Won Bae; Lee Inchul; Lee Myung Gull
Effects of water deprivation for 72 hours on the pharmacokinetics of a new carbapenem, DA-1131, in rats.
Life sciences 2002;71(19):2291-8.
2002: Shin Jieun; Cho Hawon; Hwang Sun Wook; Jung Jooyoung; Shin Chan Young; Lee Soon-Youl; Kim So Hee; Lee Myung Gull; Choi Young Hae; Kim Jinwoong; Haber Nicole Alessandri; Reichling David B; Khasar Sachia; Levine Jon D; Oh Uhtaek
Bradykinin-12-lipoxygenase-VR1 signaling pathway for inflammatory hyperalgesia.
Proceedings of the National Academy of Sciences of the United States of America 2002;99(15):10150-5.
2002: Chung Hye Chin; Kim So Hee; Lee Myung Gull; Kim Sang Geon
Increase in urea in conjunction with L-arginine metabolism in the liver leads to induction of cytochrome P450 2E1 (CYP2E1): the role of urea in CYP2E1 induction by acute renal failure.
Drug metabolism and disposition: the biological fate of chemicals 2002;30(6):739-46.
2002: Lee Ae Kyung; Kang Keon Wook; Kim Yoon Gyoon; Cho Min Kyung; Lee Myung Gull; Shim Chang-Koo; Chung Suk Jae; Kim Sang Geon
Identification of genes enhanced by protein-calorie malnutrition by differential display polymerase chain reaction (expression of fibrinogen B beta chain, B cell translocation gene 1 and thyroid hormone responsive protein genes).
Molecular and cellular biochemistry 2002;231(1-2):163-71.
2002: Kim So Hee; Lee Myung Gull
Pharmacokinetics of ipriflavone, an isoflavone derivative, after intravenous and oral administration to rats hepatic and intestinal first-pass effects.
Life sciences 2002;70(11):1299-315.
2001: Park H W; Chung S J; Kuh H J; Chung S J; Lee M G; Shim C K
The transport of a hepatoprotective agent, isopropryl 2-(1-3-dithiethane-2-ylidene)-2[N-(4-methyl-thiazole-2-yl) carbamoyl] acetate (YH439), across Caco-2 cell monolayers.
Archives of pharmacal research 2001;24(6):584-9.
2001: Kim Y G; Cho M K; Kwon J W; Kim S G; Chung S J; Shim C K; Lee M G
Effects of cysteine on the pharmacokinetics of intravenous phenytoin in rats with protein-calorie malnutrition.
International journal of pharmaceutics 2001;229(1-2):45-55.
2001: Kim Y G; Kim H J; Kwon J W; Kim W B; Lee M G
Bioequivalence of clarithromycin tablet formulations assessed in Korean males.
International journal of clinical pharmacology and therapeutics 2001;39(8):356-61.
2001: Bae S K; Bu S C; Kim E J; Kim S H; Kim S G; Lee M G
Determination of a chemopreventive agent, Oltipraz, in rat plasma and urine by high-performance liquid chromatography.
Research communications in molecular pathology and pharmacology 2001;110(1-2):133-8.
2001: Kim E J; Lee M G
Pharmacokinetics and pharmacodynamics of intravenous bumetanide in mutant Nagase analbuminemic rats: importance of globulin binding for the pharmacodynamic effects.
Biopharmaceutics & drug disposition 2001;22(4):147-56.
2001: Kim E J; Kim S O; Lee D H; Lim H; Lee M G
Dose-dependent pharmacokinetics of a new reversible proton pump inhibitor, DBM-819, after intravenous and oral administration to rats: hepatic first-pass effect.
Biopharmaceutics & drug disposition 2001;22(3):119-28.
2001: Shim H J; Lee E J; Kim J H; Kim S H; Kwon J W; Kim W B; Cha S W; Lee M G
Subacute toxicities and toxicokinetics of a new erectogenic, DA-8159, after single and 4-week repeated oral administration in dogs.
Biopharmaceutics & drug disposition 2001;22(3):109-17.
2001: Kim Y G; Cho M K; Kwon J W; Kim S G; Kim S H; Lee M G
Effects of cysteine on the pharmacokinetics and pharmacodynamics of intravenous and oral azosemide in rats with protein-calorie malnutrition.
Life sciences 2001;68(21):2329-45.
2001: Lee M H; Kim H J; Kim S H; Kim S O; Lee D H; Lim H; Yoo S E; Lee M G
High-performance liquid chromatographic analysis of a new neuroprotective agent for ischemia-reperfusion damage, KR-31378.
Research communications in molecular pathology and pharmacology 2001;109(3-4):249-56.
2001: Chung H C; Kim S H; Lee M G; Cho C K; Kim T H; Lee D H; Kim S G
Mitochondrial dysfunction by gamma-irradiation accompanies the induction of cytochrome P450 2E1 (CYP2E1) in rat liver.
Toxicology 2001;161(1-2):79-91.
2001: Kim S G; Kim E J; Kim Y G; Lee M G
Expression of cytochrome P-450s and glutathione S-transferases in the rat liver during water deprivation: effects of glucose supplementation.
Journal of applied toxicology : JAT 2001;21(2):123-9.
2001: Kim Y G; Lee Y J; Kim H J; Lee S D; Kwon J W; Kim W B; Shim C K; Lee M G
Bioequivalence of two aceclofenac tablet formulations after a single oral dose to healthy male Korean volunteers.
International journal of clinical pharmacology and therapeutics 2001;39(2):83-8.
2001: Cho M K; Kim Y G; Lee M G; Kim S G
Prevention of c-Jun/activator protein-1 activation and microsomal epoxide hydrolase induction in the rat liver by cysteine during protein-calorie malnutrition.
Biochemical pharmacology 2001;61(1):15-24.
2001: Lee M H; Kim H J; Kim S H; Kim S O; Lee D H; Lim H; Yoo S E; Lee M G
Blood partition and protein binding of a new neuroprotective agent for ischemia-reperfusion damage, KR-31378.
Research communications in molecular pathology and pharmacology 2001;110(5-6):361-70.
2001: Kim Y G; Cho M K; Kwon J W; Kim S H; Kim S G; Lee M G
No effect of cysteine on the pharmacokinetics of intravenous azosemide in rats with protein-calorie malnutrition by pretreatment with 3-methylcholanthrene.
Research communications in molecular pathology and pharmacology 2001;110(5-6):347-60.
2001: Bu S C; Kim E J; Kim S H; Kim S G; Lee M G
Stability, blood partition and protein binding of an antifibrotic agent, oltipraz.
Research communications in molecular pathology and pharmacology 2001;109(5-6):333-44.
2000: Hurh E; Lee E J; Kim Y G; Kim S Y; Kim S H; Kim Y C; Lee M G
Effects of physostigmine on the pharmacokinetics of intravenous parathion in rats.
Biopharmaceutics & drug disposition 2000;21(8):331-8.
2000: Kim H J; Han K S; Kim Y G; Chung Y K; Chang M S; Lee M G
Pharmacokinetics of a new proton pump inhibitor, YJA-20379-8, after intravenous and oral administration to spontaneously hypertensive rats and DOCA-salt-induced hypertensive rats.
Biopharmaceutics & drug disposition 2000;21(8):293-302.
2000: Kim E J; Han K S; Lee M G
Gastrointestinal first-pass effect of furosemide in rats.
The Journal of pharmacy and pharmacology 2000;52(11):1337-43.
2000: Shim H J; Lee E J; Kim S H; Kim S H; Yoo M; Kwon J W; Kim W B; Lee M G
Factors influencing the protein binding of a new phosphodiesterase V inhibitor, DA-8159, using an equilibrium dialysis technique.
Biopharmaceutics & drug disposition 2000;21(7):285-91.
2000: Kim H J; Kim S H; Kim S O; Lee D H; Lim H; Yoo S E; Lee M G
Dose-dependent pharmacokinetics of a new neuroprotective agent for ischemia-reperfusion damage, KR-31378, in rats.
Biopharmaceutics & drug disposition 2000;21(7):279-84.
2000: Kim Y G; Lee Y J; Lee E D; Lee S D; Kwon J W; Kim W B; Shim C K; Lee M G
Bioequivalence assessment of closerin capsule to dura seromycin capsule of cycloserine after a single oral dose administration to healthy male volunteers.
International journal of clinical pharmacology and therapeutics 2000;38(10):461-6.
2000: Cho M K; Kim Y G; Lee M G; Kim S G
The effect of cysteine on the altered expression of class alpha and mu glutathione S-transferase genes in the rat liver during protein-calorie malnutrition.
Biochimica et biophysica acta 2000;1502(2):235-46.
2000: Kim S H; Moon Y J; Ryu C K; Lee M G
Pharmacokinetics, stability, and blood partition of 7-anilino-5,8-isoquinolinedione, a new isoquinonlinedione derivative.
Research communications in molecular pathology and pharmacology 2000;107(5-6):419-29.
2000: Kim Y G; Cho M K; Kwon J W; Kim S G; Lee M G
Effects of cysteine on the pharmacokinetics of intravenous adriamycin in rats with protein-calorie malnutrition.
Research communications in molecular pathology and pharmacology 2000;107(5-6):361-76.
2000: Kim G B; Kim Y G; Kim S H; Park H G; Jew S S; Lee M G
Pharmacokinetics, skin absorption, stability, blood partition, and protein binding of AS 2-006A, a new wound healing agent.
Biopharmaceutics & drug disposition 2000;21(3):113-9.
2000: Kim E J; Han K S; Lee M G
Intestinal first-pass effect of bumetanide in rats.
International journal of pharmaceutics 2000;194(2):193-9.
2000: Shim H J; Lee E J; Kim S H; Kim S H; Yoo M; Kwon J W; Kim W B; Lee H S; Lee M G
Pharmacokinetics, stability, and blood partition of DA-8159, a new phosphodiesterase V inhibitor.
Research communications in molecular pathology and pharmacology 2000;108(3-4):275-86.
2000: Hurh E; Lee E J; Kim Y G; Kim S Y; Kim S H; Kim Y C; Lee M G
Effects of neostigmine on the pharmacokinetics of intravenous parathion in rats.
Research communications in molecular pathology and pharmacology 2000;108(3-4):261-73.
2000: Moon Y J; Kim S H; Ryu C K; Lee M G
Factors influencing the protein binding of IQO4, a new isoquinolinedione derivative.
Research communications in molecular pathology and pharmacology 2000;108(3-4):167-77.
1999: Cho M K; Kim Y G; Lee M G; Kim S G
Suppression of rat hepatic cytochrome P450s by protein-calorie malnutrition: complete or partial restoration by cysteine or methionine supplementation.
Archives of biochemistry and biophysics 1999;372(1):150-8.
1999: Kim S H; Lee J S; Lee M G
Stability, blood partition and plasma protein binding of ipriflavone, an isoflavone derivative.
Biopharmaceutics & drug disposition 1999;20(7):355-60.
1999: Kim S H; Kwon J W; Kim W B; Lee M G
Effects of cilastatin on the pharmacokinetics of a new carbapenem, DA-1131, in rats, rabbits, and dogs.
Antimicrobial agents and chemotherapy 1999;43(10):2524-7.
1999: Kim J; Kim E J; Han K S; Chang M S; Lee M G
Gastrointestinal first-pass effect of YJA-20379-8, a new reversible proton pump inhibitor, in rats.
The Journal of pharmacy and pharmacology 1999;51(9):1031-6.
1999: Chung S Y; Han K S; Kim H J; Kim J; Chang M S; Lee M G
Gastrointestinal absorption of a new reversible proton pump inhibitor, YJA-20379-8, and its pharmacokinetics after oral administration in acetic acid-induced gastric ulcer in rats.
The Journal of pharmacy and pharmacology 1999;51(9):1025-30.
1999: Chung S Y; Han K S; Shon S K; Chang M S; Lee M G
Pharmacokinetics of a new proton-pump inhibitor, YJA-20379-8, after intravenous and oral administration to rats with streptozotocin-induced diabetes mellitus.
The Journal of pharmacy and pharmacology 1999;51(8):929-34.
1999: Han K S; Lee M G
Effect of a new chemoprotective agent, 2-(allylthio)pyrazine, on the pharmacokinetics of intravenous theophylline in rats.
International journal of pharmaceutics 1999;184(2):237-42.
1999: Kim S H; Kim W B; Lee M G
Pharmacokinetic changes of a new carbapenem, DA-1131, after intravenous administration to spontaneously hypertensive rats and deoxycorticosterone acetate-salt-induced hypertensive rats.
Drug metabolism and disposition: the biological fate of chemicals 1999;27(6):710-6.
1999: Lee Y S; Han K S; Lee M G
Gender differences in pharmacokinetics and pharmacodynamics of azosemide in rats.
Biopharmaceutics & drug disposition 1999;20(4):225-9.
1999: Kim S H; Kim W B; Kwon J W; Lee M G
Nephroprotective effect of betamipron on a new carbapenem, DA-1131, in rabbits.
Biopharmaceutics & drug disposition 1999;20(3):125-9.
1999: Han K S; Lee M G
Pharmacokinetics of a chemoprotective agent, 2-(allylthio)pyrazine, after intravenous and oral administration to rats: hepatic and gastric first-pass effects.
Drug metabolism and disposition: the biological fate of chemicals 1999;27(2):221-6.
1999: Kim S H; Park J M; Ryu C K; Lee M G
Determination of a new naphthoquinone derivative, NQ12, in human plasma and urine by high-performance liquid chromatography.
Research communications in molecular pathology and pharmacology 1999;103(1):101-7.
1999: Kim S H; Kim W B; Lee M G
Effect of probenecid on the renal excretion mechanism of a new carbapenem, DA-1131, in rats and rabbits.
Antimicrobial agents and chemotherapy 1999;43(1):96-9.
1999: Lee H J; Lee M G
Effects of dexamethasone on the pharmacokinetics of adriamycin after intravenous administration to rats.
Research communications in molecular pathology and pharmacology 1999;105(1-2):87-96.
1999: Kim G B; Kim Y G; Jew S S; Lee M G
Determination of a new asiatic acid derivative, AS 2-006A in rat plasma and urine, and human plasma by high-performance liquid chromatography.
Research communications in molecular pathology and pharmacology 1999;104(3):339-44.
1999: Kim S H; Kim H J; Ryu C K; Lee M G
Stability, blood partition, and protein binding of NQ12, a new naphthoquinone derivative.
Research communications in molecular pathology and pharmacology 1999;104(2):165-72.
1999: Kim E J; Han K S; Lee M G
Enhanced absorption of oral furosemide by bile juice in rats.
Research communications in molecular pathology and pharmacology 1999;104(1):107-10.
1998: Kim J; Han K S; Lee J W; Lee M G
Hepatic and intestinal first-pass effects of a new hepatoprotective agent, YH439, in rats.
Research communications in molecular pathology and pharmacology 1998;102(2):125-36.
1998: Han K S; Kim Y G; Yoo J K; Lee J W; Lee M G
Pharmacokinetics of a new reversible proton pump inhibitor, YH1885, after intravenous and oral administrations to rats and dogs: hepatic first-pass effect in rats.
Biopharmaceutics & drug disposition 1998;19(8):493-500.
1998: Kim H J; Han K S; Chung Y K; Chang M S; Lee M G
Pharmacokinetic changes of a new proton pump inhibitor, YJA-20379-8, after intravenous and oral administration to rats with uranyl nitrate-induced acute renal failure.
Research communications in molecular pathology and pharmacology 1998;102(1):43-56.
1998: Yim H K; Kang H M; Lee M G; Kim Y C
Blood sampling site-dependent plasma concentrations and hepatotoxic parameters in serum after intraperitoneal administration of acetaminophen to rats.
Research communications in molecular pathology and pharmacology 1998;101(3):269-74.
1998: Han K S; Kim Y G; Lee J W; Lee M G
Blood partition and protein binding of a new reversible proton pump inhibitor, YH1885.
Biopharmaceutics & drug disposition 1998;19(6):413-5.
1998: Park J H; Lee W I; Yoon W H; Park Y D; Lee J S; Lee M G
Pharmacokinetic and pharmacodynamic changes of furosemide after intravenous and oral administration to rats with alloxan-induced diabetes mellitus.
Biopharmaceutics & drug disposition 1998;19(6):357-64.
1998: Han K S; Woo S J; Koo C H; Lee M G
Stability, blood partition, and protein binding of a chemoprotective agent, 2-(allylthio)pyrazine.
Research communications in molecular pathology and pharmacology 1998;101(2):171-8.
1998: Kim H J; Han K S; Chung Y K; Chang M S; Lee M G
Pharmacokinetics of a new proton pump inhibitor, YJA-20379-8, in rats with 48-hour water deprivation.
Research communications in molecular pathology and pharmacology 1998;101(2):137-46.
1998: Kim S H; Kim W B; Lee M G
No effect of probenecid on the renal excretion mechanism of a new carbapenem, DA-1131, in dogs.
Research communications in molecular pathology and pharmacology 1998;101(1):85-92.
1998: Han K S; Lee M G
Circadian changes in the pharmacokinetics and pharmacodynamics of azosemide in rats.
The Journal of pharmacy and pharmacology 1998;50(7):767-74.
1998: Kim S H; Kim W B; Lee M G
Pharmacokinetics of a new carbapenem, DA-1131, after intravenous administration to rats with alloxan-induced diabetes mellitus.
Biopharmaceutics & drug disposition 1998;19(5):303-8.
1998: Han K S; Woo S J; Koo C H; Lee M G
Determination of a chemoprotective agent, 2-(allylthio)pyrazine, in plasma, urine and tissue homogenates by high-performance liquid chromatography.
Journal of chromatography. B, Biomedical sciences and applications 1998;710(1-2):239-42.
1998: Roh J K; Rha S Y; Lee C I; Lee K H; Lee J J; Shim H J; Lee S D; Kim W B; Yang J; Kim S H; Lee M G
Phase I clinical trial: pharmacokinetics of a novel anthracycline, DA-125 and metabolites. Single dose study.
International journal of clinical pharmacology and therapeutics 1998;36(6):312-9.
1998: Chung S Y; Han K S; Chung Y K; Chang M S; Lee M G
Stability, blood partition, and pharmacokinetics of a new proton pump inhibitor, YJA-20379-8.
Research communications in molecular pathology and pharmacology 1998;100(2):187-200.
1998: Kwak M K; Lee W I; Kim N D; Lee M G
Metabolic changes of acetaminophen after intravenous administration to rats pretreated with 2-(allylthio)pyrazine.
Biopharmaceutics & drug disposition 1998;19(4):273-7.
1998: Kim S H; Kim W B; Lee M G
Interspecies pharmacokinetic scaling of a new carbapenem, DA-1131, in mice, rats, rabbits and dogs, and prediction of human pharmacokinetics.
Biopharmaceutics & drug disposition 1998;19(4):231-5.
1998: Kim S H; Kwon J W; Lee M G
Pharmacokinetics and tissue distribution of a new carbapenem DA-1131, after intravenous administration to mice, rats, rabbits and dogs.
Biopharmaceutics & drug disposition 1998;19(4):219-29.
1998: Kim S H; Shim H J; Kim W B; Lee M G
Pharmacokinetics of a new carbapenem, DA-1131, after intravenous administration to rats with uranyl nitrate-induced acute renal failure.
Antimicrobial agents and chemotherapy 1998;42(5):1217-21.
1998: Lee M G; Chiou W L
Mechanism of ascorbic acid enhancement of the bioavailability and diuretic effect of furosemide.
Drug metabolism and disposition: the biological fate of chemicals 1998;26(5):401-7.
1998: Han K S; Woo S J; Koo C H; Lee M G
Pharmacokinetics of a chemoprotective agent, 2-(allylthio)pyrazine, after intravenous administration to rabbits.
Research communications in molecular pathology and pharmacology 1998;100(1):29-34.
1998: Park K J; Yoon W H; Kim S H; Shin W G; Lee M G
Pharmacokinetic and pharmacodynamic changes of azosemide after intravenous and oral administration of azosemide to uranyl nitrate-induced acute renal failure rats.
Biopharmaceutics & drug disposition 1998;19(3):141-6.
1998: Choi Y J; Lee H J; Kwon J W; Kim W B; Yang J; Lee M G
Pharmacokinetic changes of M1, M2, M3 and M4 after intravenous administration of a new anthracycline, DA-125, to rats pretreated with phenobarbital, 3-methylcholanthrene, chloramphenicol, or SKF-525A.
Biopharmaceutics & drug disposition 1998;19(2):79-89.
1998: Yoon W H; Yoo J K; Lee J W; Shim C K; Lee M G
Species differences in pharmacokinetics of a hepatoprotective agent, YH439, and its metabolites, M4, M5, and M7, after intravenous and oral administration to rats, rabbits, and dogs.
Drug metabolism and disposition: the biological fate of chemicals 1998;26(2):152-63.
1998: Yoon W H; Yoo J K; Lee J W; Shim C K; Lee M G
Simultaneous determination of a new hepatoprotective agent, YH439, and its metabolites, M4, M5, and M7 in plasma and urine by high-performance liquid chromatography.
Research communications in molecular pathology and pharmacology 1998;99(1):117-24.
1997: Kim S H; Lee J S; Lee M G
Determination of a isoflavone derivative, ipriflavone, and its metabolites, M1 and M5, in rat plasma, urine, and tissue homogenate by high-performance liquid chromatography.
Research communications in molecular pathology and pharmacology 1997;98(3):313-24.
1997: Chung S Y; Yoon W H; Kim S H; Hwang K S; Lee M G
Arterial and venous blood sampling in pharmacokinetic studies: bumetanide in rabbits.
Research communications in molecular pathology and pharmacology 1997;98(3):255-64.
1997: Lee W I; Yoon W H; Shin W G; Song I S; Lee M G
Pharmacokinetics and pharmacodynamics of furosemide after direct administration into the stomach or duodenum.
Biopharmaceutics & drug disposition 1997;18(9):753-67.
1997: Kim S H; Han K S; Choi W S; Chang M S; Lee M G
Stability, blood partition, and pharmacokinetics of a new reversible proton pump inhibitor, YJA-20379-1.
Research communications in molecular pathology and pharmacology 1997;98(1):77-84.
1997: Park K J; Yoon W H; Shin W G; Lee M G
Effects of the rate and composition of fluid replacement on the pharmacokinetics and pharmacodynamics of intravenous azosemide.
Biopharmaceutics & drug disposition 1997;18(7):595-610.
1997: Kim J; Kim S H; Lee M G
Liver and gastrointestinal first-pass effects of azosemide in rats.
The Journal of pharmacy and pharmacology 1997;49(9):878-83.
1997: Kim S H; Kim S H; Lee S D; Kim W B; Lee M G; Kim N D
Determination of a new antiulcer agent, eupatilin, in rat plasma, bile, urine, and liver homogenate by high-performance liquid chromatography.
Research communications in molecular pathology and pharmacology 1997;97(2):165-70.
1997: Han K S; Choi H C; Yoo J K; Lee J W; Lee M G
Determination of a new proton pump inhibitor, YH1885, in human plasma and urine by high-performance liquid chromatography.
Journal of chromatography. B, Biomedical sciences and applications 1997;696(2):312-6.
1997: Kim S H; Choi W S; Chang M S; Lee M G
Determination of a new antiulcer agent, YJA-20379-1 in plasma, urine, blood, and tissue homogenates by high-performance liquid chromatography.
Research communications in molecular pathology and pharmacology 1997;97(1):107-12.
1997: Lee S H; Lee M G
Effect of phenobarbital, 3-methylcholanthrene, and chloramphenicol pretreatment on the pharmacokinetics and pharmacodynamics of azosemide in rats.
Biopharmaceutics & drug disposition 1997;18(5):371-86.
1997: Lee H J; Lee M G
Pharmacokinetics of adriamycin and adriamycinol after intravenous administration of adriamycin to rats with water-deprivation for 48 hours.
Research communications in molecular pathology and pharmacology 1997;96(3):299-306.
1997: Yoon W H; Park S J; Kim I C; Lee M G
Pharmacokinetics of recombinant human erythropoietin in rabbits and 3/4 nephrectomized rats.
Research communications in molecular pathology and pharmacology 1997;96(2):227-40.
1997: Kim S H; Kwon J W; Yang J; Lee M G
Determination of a new carbapenem derivative, DA-1131, in plasma and urine by high-performance liquid chromatography.
Journal of chromatography. B, Biomedical sciences and applications 1997;688(1):95-9.
1997: Yoon E J; Shim H J; Lee J J; Lee S D; Kim W B; Yang J; Lee M G
Pharmacokinetics of DA-125, a new anthracycline, after intravenous administration to spontaneously hypertensive rats and DOCA-salt-induced hypertensive rats.
Drug metabolism and disposition: the biological fate of chemicals 1997;25(1):66-74.
1997: Park K J; Yoon W H; Shin W G; Lee M G
The effect of intravenous infusion time on the pharmacokinetics and pharmacodynamics of the same total dose of azosemide in rabbits.
Biopharmaceutics & drug disposition 1997;18(1):41-52.
1996: Lee S H; Lee M G
Pharmacokinetics and pharmacodynamics of azosemide after intravenous and oral administration to rats: absorption from various GI segments.
Journal of pharmacokinetics and biopharmaceutics 1996;24(6):551-68.
1996: Yoon W H; Kim S H; Chung S Y; Chang M S; Choi W S; Sohn S K; Lee M G
Determination of a new antiulcer agent, YJA-20379-2, in human plasma and urine by high-performance liquid chromatography.
Research communications in molecular pathology and pharmacology 1996;94(3):317-22.
1996: Choi Y J; Lee H J; Kwon J W; Kim W B; Yang J; Lee M G
Pharmacokinetic changes of M1, M2, M3, and M4 after intravenous administration of a new anthracycline, DA-125, to alloxan-induced diabetes mellitus rats.
Research communications in molecular pathology and pharmacology 1996;94(2):181-92.
1996: Lee E D; Lee S D; Kim W B; Yang J; Kim S H; Lee M G
Determination of a new carbapenem antibiotic, DA-1131, in rat plasma, urine, and bile by column-switching high-performance liquid chromatography.
Research communications in molecular pathology and pharmacology 1996;94(2):171-80.
1996: Park K J; Yoon W H; Shin W G; Lee M G
Pharmacokinetics and pharmacodynamics of azosemide after intravenous and oral administration to rats with alloxan-induced diabetes mellitus.
The Journal of pharmacy and pharmacology 1996;48(10):1093-7.
1996: Lee S D; Lee W I; Shim H J; Lee E D; Kim W B; Yang J; Kim C K; Lee M G
Pharmacokinetics of four metabolites of DA-125, a new anthracycline antineoplastic agent after single and multiple intravenous administration to rats.
Journal of clinical pharmacy and therapeutics 1996;21(4):201-13.
1996: Ha H A; Lee S H; Kim S H; Kim O N; Lee M G
Effect of water deprivation for 48 hours on the pharmacokinetics and pharmacodynamics of azosemide in rats.
Research communications in molecular pathology and pharmacology 1996;93(1):109-28.
1996: Yoon E J; Lee W I; Shim H J; Lee S D; Kim W B; Yang J; Lee M G
Comparison of pharmacokinetics of M1, M2, M3, and M4 after intravenous administration of DA-125 or ME2303 to mice and rats. New adriamycin analogues containing fluorine.
Biopharmaceutics & drug disposition 1996;17(5):373-420.
1996: Kim Y G; Yoon E J; Yoon W H; Shim H J; Lee S D; Kim W B; Yang J; Lee M G
Pharmacokinetics of DA-125, a new anthracycline, after intravenous administration to uranyl nitrate-induced acute renal failure rats or protein-calorie malnutrition rats.
Biopharmaceutics & drug disposition 1996;17(3):183-95.
1996: Kim S H; Park K J; Yoon W H; Lee J W; Kim N D; Lee M G
Effect of a hepatoprotective agent, YH-439, on the pharmacokinetics of furosemide and azosemide in rats.
Research communications in molecular pathology and pharmacology 1996;91(2):233-44.
1996: Lee H J; Paik W H; Lee M G
Pharmacokinetic and tissue distribution changes of adriamycin and adriamycinol after intravenous administration of adriamycin to uranyl nitrate-induced acute renal failure rats.
Research communications in molecular pathology and pharmacology 1996;91(2):195-204.
1996: Shim H J; Lee J J; Lee S D; Kim W B; Yang J; Kim S H; Lee M G
Stability, blood partition, and protein binding of DA-5018, a new nonnarcotic analgesic.
Research communications in molecular pathology and pharmacology 1996;91(1):97-108.
1996: Cho E; Jang S H; Lee J W; Kim N D; Lee M G
Metabolic changes of acetaminophen after intravenous administration to rats pretreated with a hepatoprotective agent, YH-439.
Research communications in molecular pathology and pharmacology 1996;91(1):3-16.
1995: Kim S H; Kim W B; Lee M G
Stability, tissue metabolism, tissue distribution, and blood partition of DA-1131, a new carbapenem.
Research communications in molecular pathology and pharmacology 1995;90(3):347-62.
1995: Lee W I; Yoon W H; Park J H; Lee J W; Shim C K; Lee M G
Factors influencing the protein binding of YH-439 using an equilibrium dialysis technique. A new hepatoprotective agent.
Biopharmaceutics & drug disposition 1995;16(9):775-89.
1995: Lee S H; Lee M G
Factors influencing the protein binding of azosemide using an equilibrium dialysis technique.
Biopharmaceutics & drug disposition 1995;16(7):615-26.
1995: Lee S H; Lee M G
Stability, tissue metabolism, tissue distribution and blood partition of azosemide.
Biopharmaceutics & drug disposition 1995;16(7):547-61.
1995: Lee H J; Paik W H; Lee M G
Pharmacokinetic and tissue distribution changes of adriamycin and adriamycinol after intravenous administration of adriamycin to alloxan-induced diabetes mellitus rats.
Research communications in molecular pathology and pharmacology 1995;89(2):165-78.
1995: Lee S D; Park J B; Lee W I; Shim H J; Lee E D; Lee J J; Kim W B; Yang J; Kim C K; Lee M G
Pharmacokinetics and antitumour activity of a new anthracycline, DA-125, after intravenous administration to subcutaneously implanted Lewis-lung-carcinoma-bearing mice.
Biopharmaceutics & drug disposition 1995;16(6):489-505.
1995: Kim M M; Lee S H; Lee M G; Hwang S J; Kim C K
Pharmacokinetics of methotrexate after intravenous and intramuscular injection of methotrexate-bearing positively charged liposomes to rats.
Biopharmaceutics & drug disposition 1995;16(4):279-93.
1995: Kim E J; Yoon W H; Lee W I; Kim O N; Lee M G
The effect of dehydration on the disposition kinetics of propranolol in rats.
Biopharmaceutics & drug disposition 1995;16(3):251-7.
1995: Hwang S J; Park J M; Lee W I; Kim O N; Lee M G
The effect of water deprivation on the pharmacokinetics of methotrexate in rats.
Biopharmaceutics & drug disposition 1995;16(3):245-50.
1995: Kang M J; Yoon W H; Kim O N; Lee M G
Effects of water deprivation for 48 hours on the pharmacokinetics and pharmacodynamics of furosemide in rats.
Journal of clinical pharmacy and therapeutics 1995;20(1):13-21.
1995: Yoon W H; Lee S H; Lee M G
Effects of the rate and composition of fluid replacement on the pharmacokinetics and pharmacodynamics of intravenous bumetanide.
Journal of pharmaceutical sciences 1995;84(2):236-42.
1994: Park J M; Ahn B N; Yoon E J; Lee M G; Shim C K; Kim C K
The pharmacokinetics of methotrexate after intravenous administration of methotrexate-loaded proliposomes to rats.
Biopharmaceutics & drug disposition 1994;15(5):391-407.
1994: Jang S H; Lee M H; Lee M G
Pharmacokinetics of acetaminophen after intravenous and oral administration to spontaneously hypertensive rats and normotensive Wistar rats.
Journal of pharmaceutical sciences 1994;83(6):810-4.
1994: Shim H J; Lee E D; Yoon E J; Lee S D; Kim W B; Yang J; Lee M G
Simultaneous determination of a new anthracycline, DA-125, and its metabolites M1, M2, M3 and M4 in plasma and urine by high-performance liquid chromatography.
Journal of chromatography. B, Biomedical applications 1994;656(2):407-14.
1994: Lee S H; Lee M G
Determination of azosemide and its metabolite in plasma, blood, urine and tissue homogenates by high-performance liquid chromatography.
Journal of chromatography. B, Biomedical applications 1994;656(2):367-72.
1994: Lee S H; Shin W G; Lee M G; Kim N D
Arterial and venous blood sampling in pharmacokinetic studies: azosemide in rabbits.
Biopharmaceutics & drug disposition 1994;15(4):305-16.
1994: Jang S H; Lee M G; Kim N D
Pharmacokinetics and pharmacodynamics of furosemide after intravenous and oral administration to spontaneously hypertensive rats and DOCA-salt-induced hypertensive rats.
Biopharmaceutics & drug disposition 1994;15(3):185-206.
1994: Lee S H; Lee M G; Kim N D
Pharmacokinetics and pharmacodynamics of bumetanide after intravenous and oral administration to rats: absorption from various GI segments.
Journal of pharmacokinetics and biopharmaceutics 1994;22(1):1-17.
1993: Kim S H; Lee M G
Influence of protein and calorie malnutrition on the pharmacokinetics and pharmacodynamics of bumetanide in rats.
Journal of pharmaceutical sciences 1993;82(8):838-43.
1993: Han K S; Lee S H; Lee M G; Kim N D
Pharmacokinetics and pharmacodynamics of bumetanide after intravenous and oral administration to spontaneously hypertensive rats and DOCA-salt induced hypertensive rats.
Biopharmaceutics & drug disposition 1993;14(6):533-48.
1993: Huang J Y; Kim O N; Lee S H; Lee M G
Effects of water deprivation on the pharmacokinetics and pharmacodynamics of bumetanide in rats.
Biopharmaceutics & drug disposition 1993;14(6):463-74.
1993: Ryoo S H; Lee M G; Lee M H
Effect of intravenous infusion time on the pharmacokinetics and pharmacodynamics of the same total dose of bumetanide.
Biopharmaceutics & drug disposition 1993;14(3):245-55.
1993: Shin W G; Lee M G; Lee M H
Arterial and venous blood samplings in pharmacokinetic studies: vancomycin in rabbits.
Journal of clinical pharmacy and therapeutics 1993;18(2):115-22.
1993: Kim S H; Choi Y M; Lee M G
Pharmacokinetics and pharmacodynamics of furosemide in protein-calorie malnutrition.
Journal of pharmacokinetics and biopharmaceutics 1993;21(1):1-17.
1992: Shin W G; Lee M G; Lee M H; Kim N D
Pharmacokinetics of drugs in blood. VII: Unusual distribution and blood storage effect of vancomycin.
Biopharmaceutics & drug disposition 1992;13(4):305-10.
1991: Shin W G; Lee M G; Lee M H; Kim N D
Factors influencing the protein binding of vancomycin.
Biopharmaceutics & drug disposition 1991;12(9):637-46.
1991: Choi Y M; Kim S H; Lee M G
Effects of phenobarbital and 3-methylcholanthrene pretreatment on the pharmacokinetics and pharmacodynamics of furosemide in rats.
Journal of pharmaceutical sciences 1991;80(7):638-42.
1991: Choi Y M; Lee S H; Jang S H; Lee M G
Effects of phenobarbital and 3-methylcholanthrene pretreatment on the pharmacokinetics and the pharmacodynamics of bumetanide in rats.
Biopharmaceutics & drug disposition 1991;12(4):311-24.
1987: Hsu F H; Prueksaritanont T; Lee M G; Chiou W L
The phenomenon and cause of the dose-dependent oral absorption of chlorothiazide in rats: extrapolation to human data based on the body surface area concept.
Journal of pharmacokinetics and biopharmaceutics 1987;15(4):369-86.
1986: Lee M G; Lui C Y; Chiou W L
Pharmacokinetics of drugs in blood. V: Aberrant blood and plasma concentration profiles of methotrexate during intravenous infusion.
Biopharmaceutics & drug disposition 1986;7(5):487-94.
1986: Prueksaritanont T; Lee M G; Hsu F H; Chiou W L
Absorption of iothalamate after oral administration and absorption enhancement by amino acids in dogs and rats.
Biopharmaceutics & drug disposition 1986;7(5):463-78.
1986: Prueksaritanont T; Lui C Y; Lee M G; Chiou W L
Renal and non-renal clearances of iothalamate.
Biopharmaceutics & drug disposition 1986;7(4):347-55.
1985: Lui C Y; Lee M G; Chiou W L
Urinary pH and urine flow independent renal clearance of methotrexate in dogs.
Journal of pharmacokinetics and biopharmaceutics 1985;13(2):159-71.
1985: Lui C Y; Lee M G; Chiou W L
Clearance studies of methotrexate in dogs after multiple-rate infusion.
Cancer research 1985;45(4):1545-8.
1984: Lui C Y; Lee M G; Chiou W L
Concentration and pH dependent steady-state volume of distribution of methotrexate estimated by a simple physiologically based method.
Journal of pharmacokinetics and biopharmaceutics 1984;12(6):597-610.
1984: Lee M G; Lui C Y; Chen M L; Chiou W L
Pharmacokinetics in blood IV: unusual distribution, storage effect and metabolism of methotrexate.
International journal of clinical pharmacology, therapy, and toxicology 1984;22(10):530-7.

Sign-in to see more